drugset / Trial / NCT01097460
MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label Phase 1 trial of MM-111 in combination with Herceptin.
Timeline
- Start
- 2010-04
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MM-111 | Unknown | — | Intravenous |
| Subject | Trastuzumab | Monoclonal antibody | — | Intravenous |